RHYTHM PHARMACEUTICALS, INC. Total Liabilities
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Total Liabilities of $219.97 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-04
- 2026-06-30: Liabilities $219.97M.
- 2026-03-31: Liabilities $204.70M.
- 2025-12-31: Liabilities $210.17M.
- 2025-09-30: Liabilities $211.19M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $219.97M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $204.70M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $210.17M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $211.19M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $239.15M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $223.60M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $227.72M 10-K · filed 2026-02-26 |
| 2024-09-30 | $210.88M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $202.35M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $197.07M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $162.99M 10-K · filed 2025-02-28 |
| 2023-09-30 | $156.72M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $127.66M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $125.92M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $118.22M 10-K · filed 2024-02-29 |
| 2022-09-30 | $108.42M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $82.05M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $49.05M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $45.37M 10-K · filed 2023-03-01 |
| 2021-09-30 | $33.56M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $36.70M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $41.26M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $20.55M 10-K · filed 2022-03-01 |
| 2020-09-30 | $18.54M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $17.73M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $20.66M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $27.50M 10-K · filed 2021-03-01 |
| 2019-09-30 | $28.42M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $29.42M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $16.01M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $13.95M 10-K · filed 2020-03-02 |
| 2018-09-30 | $8.09M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $7.43M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $5.79M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $6.95M 10-K · filed 2019-03-08 |
| 2017-09-30 | $5.71M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $5.04M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |